This paper reviews the current evidence on the pathogenesis, clinical manifestations,
diagnosis and management of cancer-associated non-bacterial thrombotic endocarditis …

Circulating tumor cells (CTCs) that survive in the blood are playing an important role in the
metastasis process of tumor. In addition, they have become a tool for tumor diagnosis …

Background Patients with cancer and acute ischemic stroke (AIS) face high rates of recurrent
thromboembolism or death. Objectives To examine whether hematologic and embolic …

Ischemic stroke is an important cause of morbidity and mortality in cancer patients. The
underlying mechanisms linking cancer and stroke are not completely understood. Long …

Background and Objective Hypercoagulability is associated with increased risks of ischemic
stroke and subsequent mortality in patients with active cancer. This study investigated the …

Background and Purpose Clots rich in platelets and fibrin retrieved from patients with acute
ischemic stroke (AIS) have been shown to be independently associated with the absence of …

Cancer-related stroke (CRS), referring to ischemic stroke occurring in cancer patients
without other clear etiology, represents a clinical challenge, as it is associated with …

Purpose To assess whether the newly designed small-molecule oral P-selectin inhibitor 3 S-
1, 2, 3, 4-tetrahydro-β-carboline-3-methyl aspartyl ester (THCMA) as a nanomedicine …

Background and Objectives Patients with a new diagnosis of cancer carry an increased risk
of acute ischemic stroke (AIS), and this risk varies depending on age, cancer type, stage …

The underlying aetiopathophysiology of cancer-related strokes and thromboembolisms
differs from that of noncancer-related strokes, which makes treating cancer-related strokes …